Sales and Marketing

News

Resourceful or risky-The UKs controversial COVID-19 vaccine strategy

Valneva gets EU deal for COVID jab, and may sue UK

Shares in France's Valneva leaped after it got an EU order to supply 60 million doses of its COVID-19 vaccine VLA2001 over the next two years, including 27 million next year.

News

US buys another $1 billion-worth of Merck's COVID capsule

The US federal government has ordered another 1.4 million doses of Merck & Co and Ridgeback Biotherapeutics' oral antiviral molnupiravir for COVID-19, adding to an earlier agreement to

News

Biogen admits slow Aduhelm launch, as scientists question la...

Shares in Biogen have come under pressure after chief executive Michel Vounatsos admitted that the company is facing a much slower than anticipated rollout of its controversial Alzheimer's

News

Roche 'talking to FDA' as Alzheimer's drug moves towards 202...

Phase 3 results with Roche's amyloid-targeting Alzheimer's drug gantenerumab may not be due until the second half of last year, but the company is already in discussions with the FDA about

News